Literature DB >> 1494457

Inhibition of Candida albicans by the Peroxidase/SCN-/H2O2 system.

M Lenander-Lumikari1.   

Abstract

Effects of the salivary peroxidase (SPO) system on the growth, glucose uptake and metabolic activities of oral bacteria are well documented but the effects on oral fungi are virtually unknown. Therefore, the viability of Candida albicans (ATCC 28366) exposed to the peroxidase/SCN-/H2O2 system was studied in sterilized saliva, in phosphate-buffered saline (PBS) and in potassium chloride. The growth of C. albicans in glucose-supplemented saliva was faster at pH 5.5 than at pH 7. The addition of the complete SPO (or lactoperoxidase) system to either sterilized saliva, KCl (50 microM) or PBS at pH 5.5 inhibited dose-dependently the viability of C. albicans in KCl, but no inhibition was found in PBS or saliva. Maximal inhibition was achieved in 2 h and with > 320 microM of peroxidase-generated HOSCN/OSCN-. However, physiological salivary concentrations of phosphate (> or = 1.0 mM) and PBS blocked the antifungal effect of HOSCN/OSCN-. The relative proportions of SCN- and H2O2 were critical to the antifungal effects. With 0.2 mM KSCN, a complete loss of viability was achieved, though the HOSCN/OSCN- concentrations did not exceed 100 microM. It is concluded that C. albicans is sensitive to HOSCN/OSCN- but salivary concentrations of phosphate block the antifungal effect of the peroxidase systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494457     DOI: 10.1111/j.1399-302x.1992.tb00595.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  20 in total

1.  Dialysis unmasks the fungicidal properties of glandular salivary secretions.

Authors:  Eva J Helmerhorst; Bianca Flora; Robert F Troxler; Frank G Oppenheim
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 2.  Antimicrobial actions of dual oxidases and lactoperoxidase.

Authors:  Demba Sarr; Eszter Tóth; Aaron Gingerich; Balázs Rada
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 3.422

3.  The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells.

Authors:  Balázs Rada; Kristen Lekstrom; Sorin Damian; Corinne Dupuy; Thomas L Leto
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 4.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

5.  Selective metabolism of hypothiocyanous acid by mammalian thioredoxin reductase promotes lung innate immunity and antioxidant defense.

Authors:  Joshua D Chandler; David P Nichols; Jerry A Nick; Robert J Hondal; Brian J Day
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

6.  Nebulized thiocyanate improves lung infection outcomes in mice.

Authors:  J D Chandler; E Min; J Huang; D P Nichols; B J Day
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Biochem Pharmacol       Date:  2012-08-08       Impact factor: 5.858

8.  Oxidative epithelial host defense is regulated by infectious and inflammatory stimuli.

Authors:  Monica Valencia Gattas; Radia Forteza; Miryam A Fragoso; Nevis Fregien; Pedro Salas; Matthias Salathe; Gregory E Conner
Journal:  Free Radic Biol Med       Date:  2009-08-22       Impact factor: 7.376

9.  Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis.

Authors:  Do-Yeon Cho; Jayakar V Nayak; Dawn T Bravo; Wei Le; Alan Nguyen; Justin A Edward; Peter H Hwang; Beate Illek; Horst Fischer
Journal:  Int Forum Allergy Rhinol       Date:  2012-12-21       Impact factor: 3.858

10.  Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test.

Authors:  A Welk; Ch Meller; R Schubert; Ch Schwahn; A Kramer; H Below
Journal:  BMC Microbiol       Date:  2009-07-09       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.